Deborah Quinn

2016

In 2016, Deborah Quinn earned a total compensation of $457.3K as Chief Medical Officer at Bellerophon Therapeutics, a 17% decrease compared to previous year.

Compensation breakdown

Bonus$120,000
Option Awards$10,550
Salary$311,538
Other$15,208
Total$457,296

Quinn received $311.5K in salary, accounting for 68% of the total pay in 2016.

Quinn also received $120K in bonus, $10.6K in option awards and $15.2K in other compensation.

Rankings

In 2016, Deborah Quinn's compensation ranked 11,489th out of 14,075 executives tracked by ExecPay. In other words, Quinn earned more than 18.4% of executives.

ClassificationRankingPercentile
All
11,489
out of 14,075
18th
Division
Manufacturing
4,475
out of 5,489
19th
Major group
Chemicals And Allied Products
1,605
out of 1,895
15th
Industry group
Drugs
1,300
out of 1,538
16th
Industry
Pharmaceutical Preparations
1,009
out of 1,176
14th
Source: SEC filing on March 20, 2017.

Quinn's colleagues

We found three more compensation records of executives who worked with Deborah Quinn at Bellerophon Therapeutics in 2016.

2016

Fabian Tenenbaum

Bellerophon Therapeutics

Chief Executive Officer

2016

Peter Fernandes

Bellerophon Therapeutics

Chief Regulatory and Safety Officer

2016

Jonathan Peacock

Bellerophon Therapeutics

Chief Executive Officer

You may also like